Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry Claire S. Duvernoy, MD, Dean E. Smith, PhD, MPH, Prerana Manohar, MD, Ann Schaefer, MS, RN, Eva Kline-Rogers, MS, RNP, David Share, MD, MPH, Richard McNamara, MD, Hitinder S. Gurm, MD, Mauro Moscucci, MD, MBA American Heart Journal Volume 159, Issue 4, Pages 677-683.e1 (April 2010) DOI: 10.1016/j.ahj.2009.12.040 Copyright © 2010 Mosby, Inc. Terms and Conditions
Figure 1 Outcomes by categories of BSA (A) and categories of CrCl (B). Percentage of death for each category is stratified by gender. No significant differences in death rates for each category was detected between men and women; however, there were more women than men in the low-BSA categories and in the low-CrCl categories. American Heart Journal 2010 159, 677-683.e1DOI: (10.1016/j.ahj.2009.12.040) Copyright © 2010 Mosby, Inc. Terms and Conditions